{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:47:41Z","timestamp":1793148461321,"version":"4.5.0"},"reference-count":155,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82074104, 22177134"],"award-info":[{"award-number":["82074104, 22177134"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Cancer remains a major global health challenge, and although immunotherapy has achieved remarkable breakthroughs, its efficacy is often limited by tumor-induced immunosuppression within the tumor microenvironment (TME). Emerging evidence indicates that metabolic reprogramming plays a pivotal role in shaping the TME and regulating antitumor immune responses. Targeting tumor and immune cell metabolism has therefore become a promising strategy to enhance the effectiveness of cancer immunotherapy. This review first summarizes the metabolic reprogramming that occurs within the TME, including alterations in glucose, lipid, and amino acid metabolism in tumor cells, as well as the metabolic adaptation of immune cells. We then highlight recent advances in natural products that modulate key metabolic pathways and their potential to reshape the immunosuppressive TME. Special emphasis is placed on natural compounds that not only inhibit tumor cell metabolism but also restore the metabolic fitness of immune cells, thereby improving antitumor immunity. In addition, advances in delivery strategies, including nanocarrier-based and stimuli-responsive systems, are reviewed for their roles in improving the bioavailability, stability, and tumor targeting of natural metabolism-regulating agents. Finally, we discuss the current status and challenges of translating natural metabolism-regulating agents into clinical applications, including issues of dose optimization, safety evaluation, and patient selection. Despite these hurdles, precision targeting of metabolic pathways, interdisciplinary collaboration, and the discovery of novel compounds\u2014particularly immune-sensitizing agents derived from traditional medicine\u2014are expected to accelerate progress. Collectively, natural products represent promising adjuvant strategies for cancer immunotherapy, with great potential to overcome current therapeutic limitations and improve clinical outcomes.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1740644","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:30:21Z","timestamp":1768372221000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural products as metabolic modulators to enhance cancer immunotherapy: reprogramming the tumor microenvironment"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaoyu","family":"Fan","sequence":"first","affiliation":[{"name":"New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shushu","family":"Guo","sequence":"additional","affiliation":[{"name":"New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]},{"name":"School of Clinical Pharmacy, Shenyang Pharmaceutical University","place":["Shenyang, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanfang","family":"Li","sequence":"additional","affiliation":[{"name":"New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]},{"name":"Beijing Union-Genius Pharmaceutical Technology Development Co. Ltd.","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingyin","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Union-Genius Pharmaceutical Technology Development Co. Ltd.","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bao","sequence":"additional","affiliation":[{"name":"New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]},{"name":"Beijing Union-Genius Pharmaceutical Technology Development Co. Ltd.","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuming","family":"He","sequence":"additional","affiliation":[{"name":"Beijing Union-Genius Pharmaceutical Technology Development Co. Ltd.","place":["Beijing, China"]},{"name":"State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongtao","family":"Jin","sequence":"additional","affiliation":[{"name":"New Drug Safety Evaluation Center, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]},{"name":"Beijing Union-Genius Pharmaceutical Technology Development Co. Ltd.","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Key Technologies for Preclinical Research and Development of Innovative Drugs in Pharmacokinetics and Pharmacodynamics","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0488-6","article-title":"The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications","volume":"17","author":"Zhang","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41368-021-00131-7","article-title":"Tumor microenvironment and immune evasion in head and neck squamous cell carcinoma","volume":"13","author":"Elmusrati","year":"2021","journal-title":"Int J Oral Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13045-024-01549-2","article-title":"Immunosuppressive tumor microenvironment and immunotherapy of hepatocellular carcinoma: current status and prospectives","volume":"17","author":"Shen","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-0784","article-title":"The crossroads of cancer epigenetics and immune checkpoint therapy","volume":"29","author":"Micevic","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer\u2019s Achilles\u2019 Heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-024-01026-4","article-title":"Cancer cell metabolism and antitumour immunity","volume":"24","author":"De Martino","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.CIR-20-0791","article-title":"Fueling the revolution: targeting metabolism to enhance immunotherapy","volume":"9","author":"Leone","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/ijc.33781","article-title":"Metabolic checkpoints and novel approaches for immunotherapy against cancer","volume":"150","author":"Li","year":"2022","journal-title":"Int J Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041555","article-title":"Cancer metabolism: aspirations for the coming decade","author":"DeBerardinis","year":"2024","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00339-6","article-title":"Targeting cancer metabolism in the era of precision oncology","volume":"21","author":"Stine","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2018.3","article-title":"What has traditional Chinese medicine delivered for modern medicine","volume":"20","author":"Wang","year":"2018","journal-title":"Expert Rev Mol Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2021.01318","article-title":"The positive role of traditional Chinese medicine as an adjunctive therapy for cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Biosci Trends"},{"key":"B15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41392-020-0149-3","article-title":"Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium\/calmodulin-dependent ferroptosis","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/biof.1776","article-title":"Targeting of the tumor microenvironment by curcumin","volume":"47","author":"Fu","year":"2021","journal-title":"BioFactors"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1038\/s41598-018-20179-6","article-title":"Curcumin targets multiple enzymes involved in the ROS metabolic pathway to suppress tumor cell growth","volume":"8","author":"Larasati","year":"2018","journal-title":"Sci Rep"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/biomedicines9091086","article-title":"The role of curcumin in cancer treatment","volume":"9","author":"Zoi","year":"2021","journal-title":"Biomedicines"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-2074","article-title":"Modeling the genetic regulation of cancer metabolism: interplay between glycolysis and oxidative phosphorylation","volume":"77","author":"Yu","year":"2017","journal-title":"Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.3390\/cells10051056","article-title":"Mechanisms of metabolic reprogramming in cancer cells supporting enhanced growth and proliferation","volume":"10","author":"Schiliro","year":"2021","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang","year":"2020","journal-title":"Cell Mol Life Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1035882","article-title":"Natural products targeting glycolytic signaling pathways-an updated review on anti-cancer therapy","volume":"13","author":"Cui","year":"2022","journal-title":"Front Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-19-1789","article-title":"A tumor agnostic therapeutic strategy for hexokinase 1\u2013null\/hexokinase 2\u2013positive cancers","volume":"79","author":"Xu","year":"2019","journal-title":"Cancer Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/cancers11060813","article-title":"Hexokinase 2 regulates ovarian cancer cell migration, invasion and stemness via FAK\/ERK1\/2\/MMP9\/NANOG\/SOX9 signaling cascades","volume":"11","author":"Siu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellin.2023.100077","article-title":"Hexokinases in cancer and other pathologies","volume":"2","author":"Guo","year":"2023","journal-title":"Cell Insight"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1186\/s12885-022-10239-6","article-title":"High tumor hexokinase-2 expression promotes a pro-tumorigenic immune microenvironment by modulating CD8+\/regulatory T-cell infiltration","volume":"22","author":"Kim","year":"2022","journal-title":"BMC Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.9760","article-title":"Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer","volume":"8","author":"Anderson","year":"2017","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/cancers11030317","article-title":"Tumor energy metabolism and potential of 3-bromopyruvate as an inhibitor of aerobic glycolysis: implications in tumor treatment","volume":"11","author":"Fan","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2014.09.003","article-title":"2-Deoxy-D-glucose targeting of glucose metabolism in cancer cells as a potential therapy","volume":"355","author":"Zhang","year":"2014","journal-title":"Cancer Lett"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.acr.2023.03.001","article-title":"PFKP: More than phosphofructokinase","volume":"160","author":"Wang","year":"2023","journal-title":"Adv Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26310","article-title":"Tat-activating regulatory DNA-binding protein regulates glycolysis in hepatocellular carcinoma by regulating the platelet isoform of phosphofructokinase through microRNA 520","volume":"58","author":"Park","year":"2013","journal-title":"Hepatology"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112789","article-title":"Silencing PFKP restrains the stemness of hepatocellular carcinoma cells","volume":"407","author":"Sha","year":"2021","journal-title":"Exp Cell Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molcel.2018.03.018","article-title":"EGFR-phosphorylated platelet isoform of phosphofructokinase 1 promotes PI3K activation","volume":"70","author":"Lee","year":"2018","journal-title":"Mol Cell"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3390\/ijms22031171","article-title":"The role of PKM2 in metabolic reprogramming: insights into the regulatory roles of non-coding RNAs","volume":"22","author":"Puckett","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20214","article-title":"Fecal M2-pyruvate kinase (M2-PK): A novel marker of intestinal inflammation","volume":"13","author":"Chung-Faye","year":"2007","journal-title":"Inflammation Bowel Dis"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00159","article-title":"Pyruvate kinase M2 and cancer: the role of PKM2 in promoting tumorigenesis","volume":"10","author":"Zahra","year":"2020","journal-title":"Front Oncol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-3024","article-title":"Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells","volume":"72","author":"Tamada","year":"2012","journal-title":"Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-015-0490-2","article-title":"PKM2 promotes tumor angiogenesis by regulating HIF-1\u03b1 through NF-\u03baB activation","volume":"15","author":"Azoitei","year":"2016","journal-title":"Mol Cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00686-2","article-title":"The multiple roles of LDH in cancer","volume":"19","author":"Claps","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00022","article-title":"Lactate is always the end product of glycolysis","volume":"9","author":"Rogatzki","year":"2015","journal-title":"Front Neurosci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.2174\/138161212799504902","article-title":"Multiple biological activities of lactic acid in cancer: influences on tumor growth, angiogenesis and metastasis","volume":"18","author":"Dhup","year":"2012","journal-title":"Curr Pharm Des"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1069555","article-title":"Proton-coupled monocarboxylate transporters in cancer: From metabolic crosstalk, immunosuppression and anti-apoptosis to clinical applications","volume":"10","author":"Duan","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000000571","article-title":"Monocarboxylate transporters MCT1 and MCT4 regulate migration and invasion of pancreatic ductal adenocarcinoma cells","volume":"45","author":"Kong","year":"2016","journal-title":"Pancreas"},{"key":"B46","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41416-019-0717-x","article-title":"Monocarboxylate transporter 1 blockade with AZD3965 inhibits lipid biosynthesis and increases tumour immune cell infiltration","volume":"122","author":"Beloueche-Babari","year":"2020","journal-title":"Br J Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15171","article-title":"Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"B48","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41420-024-02106-z","article-title":"GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells","volume":"10","author":"Miller","year":"2024","journal-title":"Cell Death Discov"},{"key":"B49","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"key":"B50","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41419-024-06435-w","article-title":"Amino acid metabolism in tumor biology and therapy","volume":"15","author":"Chen","year":"2024","journal-title":"Cell Death Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115529","article-title":"Amino acids in cancer: Understanding metabolic plasticity and divergence for better therapeutic approaches","volume":"44","author":"Do","year":"2025","journal-title":"Cell Rep"},{"key":"B52","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12032-023-02014-9","article-title":"l-Asparaginase as the gold standard in the treatment of acute lymphoblastic leukemia: a comprehensive review","volume":"40","author":"Tosta P\u00e9rez","year":"2023","journal-title":"Med Oncol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1345522","article-title":"Exploiting the Achilles\u2019 heel of cancer: disrupting glutamine metabolism for effective cancer treatment","volume":"15","author":"Fan","year":"2024","journal-title":"Front Pharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.710145","article-title":"Aspartate rescues S-phase arrest caused by suppression of glutamine utilization in KRas-driven cancer cells","volume":"291","author":"Patel","year":"2016","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/receptors3040024","article-title":"The regulation and function of the amino acid transporters LAT1, ASCT2, xCT in urological cancers","volume":"3","author":"Zhao","year":"2024","journal-title":"Receptors"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-00971-9","article-title":"Targeting glutamine metabolism as a therapeutic strategy for cancer","volume":"55","author":"Jin","year":"2023","journal-title":"Exp Mol Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1007\/s12672-025-02358-w","article-title":"Serine metabolism in tumor progression and immunotherapy","volume":"16","author":"Huang","year":"2025","journal-title":"Discover Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nature22056","article-title":"Modulating the therapeutic response of tumours to dietary serine and glycine starvation","volume":"544","author":"Maddocks","year":"2017","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1096\/fj.201902690R","article-title":"Serine is required for the maintenance of redox balance and proliferation in the intestine under oxidative stress","volume":"34","author":"He","year":"2020","journal-title":"FASEB J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2013.08.048","article-title":"6-Phosphogluconate dehydrogenase regulates tumor cell migration in vitro by regulating receptor tyrosine kinase c-Met","volume":"439","author":"Chan","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2021.03.003","article-title":"Amino acid depletion therapies: starving cancer cells to death","volume":"32","author":"Butler","year":"2021","journal-title":"Trends Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1038\/s41467-020-17181-w","article-title":"Dietary glutamine supplementation suppresses epigenetically-activated oncogenic pathways to inhibit melanoma tumour growth","volume":"11","author":"Ishak Gabra","year":"2020","journal-title":"Nat Commun"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0316-7","article-title":"Histidine catabolism is a major determinant of methotrexate sensitivity","volume":"559","author":"Kanarek","year":"2018","journal-title":"Nature"},{"key":"B64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/mco2.27","article-title":"Lipid metabolism in cancer progression and therapeutic strategies","volume":"2","author":"Fu","year":"2021","journal-title":"MedComm (Beijing)"},{"key":"B65","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cmet.2019.11.010","article-title":"Greasing the wheels of the cancer machine: the role of lipid metabolism in cancer","volume":"31","author":"Snaebjornsson","year":"2020","journal-title":"Cell Metab"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-0382-T","article-title":"An essential requirement for the SCAP\/SREBP signaling axis to protect cancer cells from lipotoxicity","volume":"73","author":"Williams","year":"2013","journal-title":"Cancer Res"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.3390\/molecules25173935","article-title":"Fatty acid synthase: an emerging target in cancer","volume":"25","author":"Fhu","year":"2020","journal-title":"Molecules"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.261","article-title":"Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1\u03b1-modulated fatty acid metabolism","volume":"8","author":"Ni","year":"2017","journal-title":"Cell Death Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.132","article-title":"Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer","volume":"7","author":"Qu","year":"2016","journal-title":"Cell Death Dis"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101491","article-title":"Emerging roles for fatty acid oxidation in cancer","volume":"12","author":"Ma","year":"2025","journal-title":"Genes Dis"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1079076","article-title":"Role of CD36 in cancer progression, stemness, and targeting","volume":"10","author":"Guerrero-Rodr\u00edguez","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.3390\/cells10061472","article-title":"Phospholipase A2 drives tumorigenesis and cancer aggressiveness through its interaction with annexin A1","volume":"10","author":"Vecchi","year":"2021","journal-title":"Cells"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn783","article-title":"PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma","volume":"20","author":"Buhmeida","year":"2009","journal-title":"Ann Oncol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101510","article-title":"Arachidonic acid released by PIK3CA mutant tumor cells triggers Malignant transformation of colonic epithelium by inducing chromatin remodeling","volume":"5","author":"He","year":"2024","journal-title":"Cell Rep Med"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-1611","article-title":"Targeting arachidonic acid metabolism enhances immunotherapy efficacy in ARID1A-deficient colorectal cancer","volume":"85","author":"Cui","year":"2025","journal-title":"Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12944-025-02563-0","article-title":"Lipid rafts: novel therapeutic targets for metabolic, neurodegenerative, oncological, and cardiovascular diseases","volume":"24","author":"Warda","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B78","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3390\/cells12010064","article-title":"Relationship between tumor infiltrating immune cells and tumor metastasis and its prognostic value in cancer","volume":"12","author":"Li","year":"2022","journal-title":"Cells"},{"key":"B79","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/mco2.6","article-title":"Metabolism in tumor microenvironment: Implications for cancer immunotherapy","volume":"1","author":"Shi","year":"2020","journal-title":"MedComm (Beijing)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.01.009","article-title":"Metabolic programming and immune suppression in the tumor microenvironment","volume":"41","author":"Arner","year":"2023","journal-title":"Cancer Cell"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.04.007","article-title":"Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinoma","volume":"71","author":"Chen","year":"2019","journal-title":"J Hepatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1506849","article-title":"Crosstalk between lactate and tumor-associated immune cells: clinical relevance and insight","volume":"14","author":"Sun","year":"2024","journal-title":"Front Oncol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccell.2022.01.001","article-title":"Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments","volume":"40","author":"Kumagai","year":"2022","journal-title":"Cancer Cell"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.7150\/thno.53749","article-title":"Lactate-induced M2 polarization of tumor-associated macrophages promotes the invasion of pituitary adenoma by secreting CCL17","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.115332","article-title":"Immunometabolism of tumor-associated macrophages: A therapeutic perspective","volume":"220","author":"Karimova","year":"2025","journal-title":"Eur J Cancer"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115574","article-title":"Reprogramming the lipid metabolism of dendritic cells in tumor immunomodulation and immunotherapy","volume":"167","author":"Sun","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1038\/s41467-018-04719-2","article-title":"Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice","volume":"9","author":"Loftus","year":"2018","journal-title":"Nat Commun"},{"key":"B90","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cmet.2017.10.009","article-title":"AMPK: sensing glucose as well as cellular energy status","volume":"27","author":"Lin","year":"2018","journal-title":"Cell Metab"},{"key":"B91","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/febs.16245","article-title":"Tryptophan and its metabolites in normal physiology and cancer etiology","volume":"290","author":"Perez-Castro","year":"2023","journal-title":"FEBS J"},{"key":"B92","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.cell.2016.09.031","article-title":"L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity","volume":"167","author":"Geiger","year":"2016","journal-title":"Cell"},{"key":"B93","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00281-025-01038-9","article-title":"Arginine metabolism in myeloid cells in health and disease","volume":"47","author":"Karadima","year":"2025","journal-title":"Semin Immunopathol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"9614","DOI":"10.3390\/ijms24119614","article-title":"Comprehensive insight into colorectal cancer metabolites and lipids for human serum: A proof-of-concept study","volume":"24","author":"Bhatt","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1634413","article-title":"Multi-omics dissection of tumor microenvironment-mediated drug resistance: mechanisms and therapeutic reprogramming","volume":"16","author":"Chen","year":"2025","journal-title":"Front Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2020.09.013","article-title":"Immunometabolism in the single-cell era","volume":"32","author":"Artyomov","year":"2020","journal-title":"Cell Metab"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","article-title":"Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer","volume":"14","author":"Sun","year":"2023","journal-title":"Nat Commun"},{"key":"B98","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.3390\/cancers17213524","article-title":"Detection of protein and metabolites in cancer analyses by MALDI 2000\u20132025","volume":"17","author":"Bartusik-Aebisher","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.4c03821","article-title":"Molecular profiling of glioblastoma patient-derived single cells using combined MALDI-MSI and MALDI-IHC","volume":"97","author":"Krestensen","year":"2025","journal-title":"Anal Chem"},{"key":"B100","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.3390\/ijms20102454","article-title":"Mechanism of apoptosis induced by curcumin in colorectal cancer","volume":"20","author":"Ismail","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.3727","article-title":"Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2-mediated glycolysis","volume":"33","author":"Gao","year":"2015","journal-title":"Oncol Rep"},{"key":"B102","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41408-021-00514-3","article-title":"Acute promyelocytic leukemia current treatment algorithms","volume":"11","author":"Yilmaz","year":"2021","journal-title":"Blood Cancer J"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.6b02861","article-title":"Apple Polyphenol Phloretin Inhibits Colorectal Cancer Cell Growth via Inhibition of the Type 2 Glucose Transporter and Activation of p53-Mediated Signaling","volume":"64","author":"Lin","year":"2016","journal-title":"J Agric Food Chem"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.4233","article-title":"Apigenin inhibits the proliferation of adenoid cystic carcinoma via suppression of glucose transporter-1","volume":"12","author":"Fang","year":"2015","journal-title":"Mol Med Rep"},{"key":"B105","doi-asserted-by":"publisher","first-page":"fs2","DOI":"10.1126\/scisignal.aaf1937","article-title":"Mystery solved: Trehalose kickstarts autophagy by blocking glucose transport","volume":"9","author":"Mardones","year":"2016","journal-title":"Sci Signal"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01336","article-title":"Molecular mechanisms of action of genistein in cancer: recent advances","volume":"10","author":"Tuli","year":"2019","journal-title":"Front Pharmacol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-010-9238-z","article-title":"Inhibition of cancer cell invasion and metastasis by genistein","volume":"29","author":"Pavese","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036764","article-title":"Resveratrol inhibits cancer cell metabolism by down regulating pyruvate kinase M2 via inhibition of mammalian target of rapamycin","volume":"7","author":"Iqbal","year":"2012","journal-title":"PloS One"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2011.00049","article-title":"Anticancer targets in the glycolytic metabolism of tumors: A comprehensive review","volume":"2","author":"Porporato","year":"2011","journal-title":"Front Pharmacol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1039\/D1MD00045D","article-title":"Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agents","volume":"12","author":"Rathod","year":"2021","journal-title":"RSC Med Chem"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1820","article-title":"Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy","volume":"7","author":"Feng","year":"2018","journal-title":"Cancer Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/cac2.12080","article-title":"Targeting lactate dehydrogenase A (LDHA) exerts antileukemic effects on T-cell acute lymphoblastic leukemia","volume":"40","author":"Yu","year":"2020","journal-title":"Cancer Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1308749","article-title":"Development and evaluation of oleanolic acid dosage forms and its derivatives","volume":"2020","author":"Feng","year":"2020","journal-title":"BioMed Res Int"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2019.143956","article-title":"Oleanolic acid reduces aerobic glycolysis-associated proliferation by inhibiting yes-associated protein in gastric cancer cells","volume":"712","author":"Li","year":"2019","journal-title":"Gene"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00248.2006","article-title":"Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin","volume":"292","author":"Lim","year":"2007","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.3390\/ijms20112704","article-title":"Resveratrol action on lipid metabolism in cancer","volume":"20","author":"Kiskov\u00e1","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B117","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12935-015-0241-x","article-title":"Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy","volume":"15","author":"Ramasamy","year":"2015","journal-title":"Cancer Cell Int"},{"key":"B118","doi-asserted-by":"publisher","first-page":"7368","DOI":"10.3390\/molecules26237368","article-title":"Berberine as a potential anticancer agent: A comprehensive review","volume":"26","author":"Rauf","year":"2021","journal-title":"Molecules"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1007\/s13105-020-00783-9","article-title":"Hesperetin inhibits foam cell formation and promotes cholesterol efflux in THP-1-derived macrophages by activating LXR\u03b1 signal in an AMPK-dependent manner","volume":"77","author":"Chen","year":"2021","journal-title":"J Physiol Biochem"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118597","article-title":"Huangqin tang alleviates colitis-associated colorectal cancer via amino acids homeostasisand PI3K\/AKT\/mtor pathway modulation","volume":"334","author":"Wang","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118260","article-title":"Early administration of Wumei Wan inhibit myeloid-derived suppressor cells via PI3K\/Akt pathway and amino acids metabolism to prevent colitis-associated colorectal cancer","volume":"333","author":"Lu","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1080\/01635581.2019.1645865","article-title":"Metabolic alterations induced by Kudingcha lead to cancer cell apoptosis and metastasis inhibition","volume":"72","author":"Zhu","year":"2020","journal-title":"Nutr Cancer"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-019-04828-1","article-title":"A metabolic investigation of anticancer effect of G. glabra root extract on nasopharyngeal carcinoma cell line, C666-1","volume":"46","author":"Zheng","year":"2019","journal-title":"Mol Biol Rep"},{"key":"B124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3817879","article-title":"Metabolomic study on nude mice models of gastric cancer treated with modified Si Jun Zi Tang via HILIC UHPLC-Q-TOF\/MS analysis","volume":"2019","author":"Nie","year":"2019","journal-title":"Evidence-Based Complementary Altern Med"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1646138","article-title":"Mitochondria-targeted strategies in tumor immunity","volume":"16","author":"Cheng","year":"2025","journal-title":"Front Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.7150\/thno.107812","article-title":"Mitochondria-targeting natural product rhein conjugated with dichloroacetate as the dual inhibitor of glycolysis and oxidative phosphorylation to off energize cancer cells and induce ROS storm","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2014.01.002","article-title":"Frondoside A enhances the antiproliferative effects of gemcitabine in pancreatic cancer","volume":"50","author":"Al Shemaili","year":"2014","journal-title":"Eur J Cancer"},{"key":"B128","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.3390\/ijms20174279","article-title":"Ginsenoside compound K induces ros-mediated apoptosis and autophagic inhibition in human neuroblastoma cells in vitro and in vivo","volume":"20","author":"Oh","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07006-0","article-title":"Resveratrol reverses the Warburg effect by targeting the pyruvate dehydrogenase complex in colon cancer cells","volume":"7","author":"Saunier","year":"2017","journal-title":"Sci Rep"},{"key":"B130","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.immuni.2014.04.007","article-title":"Inflammatory T cell responses rely on amino acid transporter ASCT2 facilitation of glutamine uptake and mTORC1 kinase activation","volume":"40","author":"Nakaya","year":"2014","journal-title":"Immunity"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.aal3024","article-title":"Resveratrol stimulates the metabolic reprogramming of human CD4 + T cells to enhance effector function","volume":"10","author":"Craveiro","year":"2017","journal-title":"Sci Signal"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.3390\/antiox9111109","article-title":"Hemin prevents increased glycolysis in macrophages upon activation: protection by microbiota-derived metabolites of polyphenols","volume":"9","author":"Carrasco-Pozo","year":"2020","journal-title":"Antioxidants"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FP0060270","article-title":"Hemin modulates cytokine expressions in macrophage-derived foam cells via heme oxygenase-1 induction","volume":"103","author":"Ma","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105796","article-title":"Dioscin ameliorates murine ulcerative colitis by regulating macrophage polarization","volume":"172","author":"Wu","year":"2021","journal-title":"Pharmacol Res"},{"key":"B135","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-associated macrophages: from mechanisms to therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00431","article-title":"The role of the extracellular matrix and its molecular and cellular regulators in cancer cell plasticity","volume":"8","author":"Poltavets","year":"2018","journal-title":"Front Oncol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.08.020","article-title":"Emerging role of natural products in cancer immunotherapy","volume":"12","author":"Dong","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"B138","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032712-100008","article-title":"Immunogenic cell death in cancer therapy","volume":"31","author":"Kroemer","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4911","article-title":"Capsaicin triggers immunogenic PEL cell death, stimulates DCs and reverts PEL-induced immune suppression","volume":"6","author":"Granato","year":"2015","journal-title":"Oncotarget"},{"key":"B140","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4110\/in.2016.16.1.75","article-title":"Immunogenic cell death induced by ginsenoside Rg3: significance in dendritic cell-based anti-tumor immunotherapy","volume":"16","author":"Son","year":"2016","journal-title":"Immune Netw"},{"key":"B141","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13027-019-0247-4","article-title":"Resveratrol induces immunogenic cell death of human and murine ovarian carcinoma cells","volume":"14","author":"Zhang","year":"2019","journal-title":"Infect Agent Cancer"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.9b02875","article-title":"Nanoformulated codelivery of quercetin and alantolactone promotes an antitumor response through synergistic immunogenic cell death for microsatellite-stable colorectal cancer","volume":"13","author":"Zhang","year":"2019","journal-title":"ACS Nano"},{"key":"B143","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00262-012-1258-9","article-title":"Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine","volume":"61","author":"Chen","year":"2012","journal-title":"Cancer Immunology Immunother"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105824","article-title":"Baicalein and baicalin promote antitumor immunity by suppressing PD-L1 expression in hepatocellular carcinoma cells","volume":"75","author":"Ke","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2016.1245249","article-title":"STAT3-targeted treatment with silibinin overcomes the acquired resistance to crizotinib in ALK -rearranged lung cancer","volume":"15","author":"Cuy\u00e0s","year":"2016","journal-title":"Cell Cycle"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104727","article-title":"Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1\u03b1 and STAT3 in human colon cancer cells","volume":"155","author":"Wang","year":"2020","journal-title":"Pharmacol Res"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104623","article-title":"Modified Bu-zhong-yi-qi decoction synergies with 5 fluorouracile to inhibits gastric cancer progress via PD-1\/PD- L1-dependent T cell immunization","volume":"152","author":"Xu","year":"2020","journal-title":"Pharmacol Res"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106206","article-title":"Andrographolide potentiates PD-1 blockade immunotherapy by inhibiting COX2-mediated PGE2 release","volume":"81","author":"Liu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B149","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41419-018-1099-3","article-title":"Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota","volume":"9","author":"Dong","year":"2018","journal-title":"Cell Death Dis"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119769","article-title":"Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model","volume":"235","author":"Xu","year":"2020","journal-title":"Biomaterials"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.fitote.2010.05.001","article-title":"Applications of novel drug delivery system for herbal formulations","volume":"81","author":"Ajazuddin","year":"2010","journal-title":"Fitoterapia"},{"key":"B152","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"J Nanobiotechnol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2022.106199","article-title":"Co-delivery of Docetaxel and Resveratrol by liposomes synergistically boosts antitumor efficiency against prostate cancer","volume":"174","author":"Zhang","year":"2022","journal-title":"Eur J Pharm Sci"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S210320","article-title":"Nano encapsulated curcumin: and its potential for biomedical applications","volume":"15","author":"Chen","year":"2020","journal-title":"Int J Nanomed"},{"key":"B155","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.actbio.2016.04.026","article-title":"Paclitaxel-loaded solid lipid nanoparticles modified with Tyr-3-octreotide for enhanced anti-angiogenic and anti-glioma therapy","volume":"38","author":"Banerjee","year":"2016","journal-title":"Acta Biomater"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1740644\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:30:24Z","timestamp":1768372224000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1740644\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":155,"alternative-id":["10.3389\/fimmu.2025.1740644"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1740644","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1740644"}}